Noya Ca Pharmaceutical to Invest $14.6 Mln in Drug Production in Uzbekistan
There are plans to establish the production of psychotherapeutic drugs.
Pharmaceutics
EBRD to Provide $25 Mln Loan to Pharma Company Meros Pharm
The funding will help the distributor expand its warehouse network
Uzbek Pharma Market Projected to Grow by 13% in 2024
As stated by STADA
Uzbekistan to Introduce Duties On Imported Antibiotics
Starting from April 2025
Uzbek Pharmaceutical Startups To Receive Investments From Venture Fund
Decree signed by the Head of State
Customs Benefits for Pharmaceutical Companies Extended Until 2028
The President of Uzbekistan made this announcement
Mirziyoyev Unveils UZS 20 Billion Initiative to Strengthen Pharma Sector
The funds will be provided as grants
Juris Bundulis, Chairman of the Board of Olainfarm: Compelling Investment Opportunity in Promising Market
The Latvian pharmaceutical company aims to 'revitalise' Central Asia and has specific plans for Uzbekistan.
State investments and regulatory framework
IQVIA outlines growth conditions for Uzbekistan’s pharmaceutical market
Vladislav Bessarabov: Standardisation of Rules as a Growth Factor for the Pharmaceutical Business
What challenges do foreign companies face in the Central Asian market